We welcomed Ahn Louise Larsen, Senior Supply Chain Specialist, CMC Clinical Supplies - Supply Chain Optimisation and Solutions, Novo Nordisk to the Clinical Trial Supply Forum, which took place this May in Brussels. In this session she presented her expert insights into the optimisation of clinical trial supply forecasting and the planning required through innovative IT solutions.
CTS delegates enjoyed presentations on topics focused on one single message: Ensuring a lean and efficient clinical trial supply environment – no matter the product, market or phase.
Pharma IQ are providing an outline of the key discussions which took place, the attendees of the conference and insights into where the industry is heading.
Ahead of the Clinical Trial Supply Forum, experts from all regions and areas within clinical trial supply participated in our survey, to give us insight on the main logistical challenges that exist in global clinical trials. This survey looks at the main challenges and drivers which companies are facing and looks ahead to what this means for the future. It also looks at how things have changed over the last year.
Interested in finding out more about this event? Download the full agenda here.
In this short trailer you can find out more about what to expect at this year's Clinical Trial Supply Forum. This one-minute video gives a summary of some of the 2019 top speakers, key takeaways you will leave the event with and topics covered.
If you would like more information on this event, including the full list of speakers, sessions, sponsors and event opportunities then please view the full event guide here.
Alternatively, ahead of the forum on the 20 -22 May, we have created three exclusive complimentary pieces of content to give you an insight into the themes and key issues we will be tackling across the 3-event days. To view these please click here.
Join in the conversation or share this at #CTSForum
New labelling requirements: How is the clinical trial supply industry getting ready to stay compliant?
The new Clinical Trials Regulation is to be enforced in and the clinical trial supply industry is preparing now to remain compliant and companies will have to change their labelling process in order to save costs and stay up to date with the requirements.
In this exclusive article, we have surveyed more than 250 clinical trial supply experts from all around the world to gain insight on where their investment priorities lie in terms of labelling solutions and what their time frame is, in order to better understand how their industry is getting ready to comply with the new legislation.